You have access
Phase I Study of Everolimus, Cetuximab and Irinotecan as Second-line Therapy in Metastatic Colorectal Cancer
J. RANDOLPH HECHT, TONY R. REID, CHRISTOPHER R. GARRETT, J. THADDEUS BECK, SHELDON J. DAVIDSON, MARY J. MACKENZIE, ULRIKE BRANDT, SYED RIZVI and SUNIL SHARMA
Anticancer Research March 2015, 35 (3) 1567-1573;